Climb Bio

Redmond, United States

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

Apr 2026

Post-IPO Equity

Biotechnology Health Care Medical Neuroscience Pharmaceutical

Top Investors

RA Capital ManagementCormorant Asset ManagementJanus Henderson InvestorsAdage Capital ManagementSamsara BioCapital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Climb Bio

Who are Climb Bio's investors?

Climb Bio's investors include RA Capital Management, Cormorant Asset Management, Janus Henderson Investors, Adage Capital Management, Samsara BioCapital.

Where is Climb Bio headquartered?

Climb Bio is headquartered in Redmond, United States.

What does Climb Bio do?

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

What stage is Climb Bio at?

Climb Bio is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 28, 2026.

MLA

"Climb Bio — Funding & Investors." VCBacked, April 28, 2026, https://www.vcbacked.co/company/climb-bio. Accessed June 3, 2026.

APA

VCBacked. (2026). Climb Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/climb-bio

Wikipedia (cite web)

{{cite web |title=Climb Bio — Funding & Investors |url=https://www.vcbacked.co/company/climb-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 28, 2026.

Similar Companies in Biotechnology